1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021
2. Viennese risk prediction score for Advanced Gastroesophageal carcinoma based on Alarm Symptoms (VAGAS score): characterisation of alarm symptoms in advanced gastro-oesophageal cancer and its correlation with outcome;Puhr;ESMO Open,2020
3. Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Obermannová;Ann Oncol,2022
4. Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy;Tay;J Clin Oncol,2022
5. Food and Drug Administration. FDA grants accelerated approval to pembrolizumab for first tissue/site agnostic indication. 2017. Available at https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-pembrolizumab-first-tissuesite-agnostic-indication. Accessed June 30, 2021.